CALZF (Polynovo) Net Margin % : 5.61% (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Polynovo Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Polynovo's Net Income for the six months ended in Dec. 2024 was $2.11 Mil. Polynovo's Revenue for the six months ended in Dec. 2024 was $37.69 Mil. Therefore, Polynovo's net margin for the quarter that ended in Dec. 2024 was 5.61%.

The historical rank and industry rank for Polynovo's Net Margin % or its related term are showing as below:

CALZF' s Net Margin % Range Over the Past 10 Years
Min: -43400 Med: -21.42 Max: 5.11
Current: 5.11

CALZF's Net Margin % is ranked better than
59.44% of 816 companies
in the Medical Devices & Instruments industry
Industry Median: 0.775 vs CALZF: 5.11

Polynovo Net Margin % Historical Data

The historical data trend for Polynovo's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Polynovo Net Margin % Chart

Polynovo Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Net Margin %

Get a 7-Day Free Trial

-18.93

-15.79

-2.88

-7.55

5.10

Polynovo Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Margin %	Get a 7-Day Free Trial															-13.02	-3.07	5.71	4.58	5.61

Competitive Comparison of Polynovo's Net Margin %

For the Medical Devices subindustry, Polynovo's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Polynovo's Net Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Polynovo's Net Margin % distribution charts can be found below:

* The bar in red indicates where Polynovo's Net Margin % falls into.

Save Embed

;

Save Embed

;

Polynovo Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Polynovo's Net Margin for the fiscal year that ended in Jun. 2024 is calculated as

Net Margin	=	Net Income (A: Jun. 2024 )	/	Revenue (A: Jun. 2024 )
	=	3.493	/	68.521
	=	5.10 %

Polynovo's Net Margin for the quarter that ended in Dec. 2024 is calculated as

Net Margin	=	Net Income (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	2.114	/	37.692
	=	5.61 %

Polynovo (OTCPK:CALZF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Polynovo Net Margin % Related Terms

Thank you for viewing the detailed overview of Polynovo's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Polynovo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Polynovo Ltd (OTCPK:CALZF) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

MFJ:Germany PNV:Australia

Address

320 Lorimer Street, Unit 2, Port Melbourne, VIC, AUS, 3207

Website

https://www.polynovo.com

Polynovo earns most of its revenue from US sales of its NovoSorb Biodegradable Temporizing Matrix, or NovoSorb BTM. The product is a patented biodegradable synthetic scaffold to support the regeneration of the dermis when lost through surgery, trauma, burns, or other causes of tissue loss. Once the product is applied to a wound, it takes a few weeks for the dermal layer to fully integrate within the polymer scaffold before a clinician can delaminate the outer layer. A small wound would then close either naturally or with a dressing, while a larger wound would close through a split-skin graft or alternative product such as Avita's RECELL. NovoSorb BTM then slowly degrades to harmless byproducts which are fully absorbed in roughly 18 months.